Our MyRBQM Functional Service Provision model redefines FSP models in clinical trials with its unique, independent RBQM solutions. It offers integrated risk management strategies, AI-augmented tools like the MyRBQM Portal, and specialized training through the MyRBQM Academy, setting new industry standards.
We proudly present our virtual dialogue on Responsible AI in Clinical Trials this November 15 & 16, uniting industry and academic experts for groundbreaking discussions and insights.
Happymeter: Decoding Happiness - we measured what makes us happy! Explore global joy and key happiness contributors using data insights.
Explore the intricate balance between economy and well-being. Discover how country's GDP and health expenditure influence core health outcomes.
In a fast-changing pharma landscape, our MyRBQM® Portal transforms clinical trial and pipeline oversight and aids in M&A due diligence, offering a strategic edge in compliance and growth.
Explore how Vanguard companies, innovative small pharma entities, differ in research focus and recruitment dynamics from larger Pharma.
Phase II Vanguards data visualization tool provides oversight of groundbreaking investigational new drugs and under-the-radar institutions developing them.
In this blog, we explore the growing concerns about fraudulent RCTs highlighted in a recent Nature article. Discover how innovative risk management approaches can detect, prevent, and tackle these issues, facilitating more robust regulatory oversight.
MyRBQM Portal has made its debut on the Azure Marketplace. This milestone allows biopharmaceutical companies to streamline and unify their approach to risk management by using the secure and reliable Azure cloud platform.
How heavily do decentralized clinical trials rely on technology? We asked Craig Lipset, a leading expert in the field of decentralized clinical trials.
